Schmelzle Moritz, Krenzien Felix, Dahlke Paul, Krombholz Alina, Nevermann Nora, Feldbrügge Linda, Winter Axel, Schöning Wenzel, Benzing Christian, Pratschke Johann, Neudecker Jens
Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):20-36. doi: 10.21037/hbsn-21-294. Epub 2022 Feb 9.
Twenty-three recommendations were summarized by the Enhanced Recovery After Surgery (ERAS) society for liver surgery. The aim was to validate the protocol especially with regard to adherence and the impact on morbidity.
Using the ERAS Interactive Audit System (EIAS), ERAS items were evaluated in patients undergoing liver resection. Over a period of 26 months, 304 patients were prospectively enrolled in an observational study (DRKS00017229). Of those, 51 patients (non-ERAS) were enrolled before and 253 patients (ERAS) after the implementation of the ERAS protocol. Perioperative adherence and complications were compared between the two groups.
Overall adherence increased from 45.2% in the non-ERAS group to 62.7% in the ERAS group (P<0.001). This was associated with significant improvements in the preoperative and postoperative phase (P<0.001), rather than in the outpatient and intraoperative phase (both P>0.05). Overall complications decreased from 41.2% (n=21) in the non-ERAS group to 26.5% (n=67) in the ERAS group (P=0.0423), which was mainly due to the reduction of grade 1-2 complications from 17.6% (n=9) to 7.6% (n=19) (P=0.0322). As for patients undergoing open surgery, implementation of ERAS lead to a reduction of overall complications in patients scheduled for minimally invasive liver surgery (MILS) (P=0.036).
Implementation of the ERAS protocol for liver surgery according to the ERAS guidelines of the ERAS Society reduced Clavien-Dindo grade 1-2 complications particularly in patients who underwent MILS. The ERAS guidelines are beneficial for the outcome, while adherence to the various items has not yet been satisfactorily defined.
外科手术加速康复(ERAS)学会总结了23条肝脏手术相关建议。目的是验证该方案,特别是在依从性以及对发病率的影响方面。
使用ERAS交互式审计系统(EIAS),对接受肝切除术的患者的ERAS项目进行评估。在26个月的时间里,304例患者前瞻性纳入一项观察性研究(DRKS00017229)。其中,51例患者(非ERAS组)在ERAS方案实施前入组,253例患者(ERAS组)在方案实施后入组。比较两组的围手术期依从性和并发症情况。
总体依从性从非ERAS组的45.2%提高到ERAS组的62.7%(P<0.001)。这与术前和术后阶段的显著改善相关(P<0.001),而非门诊和术中阶段(P均>0.05)。总体并发症从非ERAS组的41.2%(n=21)降至ERAS组的26.5%(n=67)(P=0.0423),这主要归因于1-2级并发症从17.6%(n=9)降至7.6%(n=19)(P=0.0322)。对于接受开放手术的患者,ERAS方案的实施使计划进行微创肝脏手术(MILS)的患者总体并发症减少(P=0.036)。
根据ERAS学会的ERAS指南实施肝脏手术ERAS方案可降低Clavien-Dindo 1-2级并发症,特别是在接受MILS的患者中。ERAS指南对手术结果有益,而对各项建议的依从性尚未得到令人满意的界定。